GlassScriptPhysician profile
Sydney Resnik
NPI 1619555604
$3,143.97
in general payments reported to CMS, 2019-2025
20 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $305 · 2023: $423 · 2024: $1,081 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,656 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,655.60 |
| Education | $182.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $673.15 | 2022-2025 | |
| Genzyme Corporation | $531.23 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $332.00 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $296.83 | 2024-2025 | |
| Janssen Biotech, INC. | $284.63 | 2024-2025 | Tremfya |
| Incyte Corporation | $159.64 | 2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $148.88 | 2024 | Ebglyss |
| Arcutis Biotherapeutics, INC. | $142.60 | 2023-2025 | Zoryve |
| Ucb, INC. | $118.40 | 2024 | Bimzelx |
| Pfizer INC. | $99.17 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $85.81 | 2023-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $65.26 | 2024 | Vtama |
| Amgen INC. | $62.06 | 2022-2023 | Otezla |
| Medtronic, INC. | $32.36 | 2022 | |
| Galderma Laboratories, L.P. | $24.99 | 2023 | Oracea, Epsolay, Aklief |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $22.82 | 2023 | Poteligeo |
| Aurinia Pharma U.S., INC. | $19.70 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $16.26 | 2023 | Valchlor |
| Sun Pharmaceutical Industries INC. | $14.87 | 2025 | |
| Pharming Healthcare, INC. | $13.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Resnik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.